A proof-of-concept trial has shown that zoledronic acid is effective in preventing bone erosions in patients with early rheumatoid arthritis (RA). Zoledronic acid is a third-generation ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback